Ulf Lindström (U Lindström, Ulf Lindstrom)

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 27

Top Topics

Ankylosing Spondylitis

Top Venues

Annals of the rheumatic diseases

Rheumatology (Oxford, England)

Arthritis research & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ulf Lindström, Daniela di Giuseppe, Sofia Exarchou, Gerd-Marie Alenius, Tor Olofsson, Eva Klingberg, Lennart Jacobsson, Johan Askling, Johan K Wallman
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study. RMD open 9 (2) (2023)
Sofia Exarchou, Daniela Di Giuseppe, Eva Klingberg, Valgerdur Sigurdardottir, Sara Wedrén, Ulf Lindström, Carl Turesson, Lennart T H Jacobsson, Johan Askling, Johan Karlsson Wallman
Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study. Annals of the rheumatic diseases (2023)
Matilda Morin, Karin Hellgren, Ulf Lindström, Thomas Frisell
Association of childhood infections and perinatal factors with ankylosing spondylitis: a Swedish nationwide case-control and sibling study. RMD open 9 (3) (2023)
Ulf Lindström, Daniela di Giuseppe, Sofia Exarchou, Gerd-Marie Alenius, Tor Olofsson, Eva Klingberg, Lennart Jacobsson, Johan Askling, Johan K Wallman
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study. RMD open 9 (2) (2023)
Ulf Lindström, Daniela di Giuseppe, Sofia Exarchou, Gerd-Marie Alenius, Tor Olofsson, Eva Klingberg, Lennart Jacobsson, Johan Askling, Johan K Wallman
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study. RMD open 9 (2) (2023)
Pasoon Hellamand, Marleen G H van de Sande, Lykke M Ørnbjerg, Thomas Klausch, Kari K Eklund, Heikki Relas, Maria Jose Santos, Elsa Vieira-Sousa, Anne Gitte Loft, Bente Glintborg, Mikkel Østergaard, Ulf Lindström, Johan Karlsson Wallman, Brigitte Michelsen, Karen M Fagerli, Isabel Castrejon, Bjorn Gudbjornsson, Thorvardur J Love, Jiří Vencovský, Lucie Nekvindová, Žiga Rotar, Matija Tomšič, Federico Díaz-González, Gökce Kenar, Handan Y Tuğsal, Florenzo Iannone, Roberta Ramonda, Catalin Codreanu, Corina Mogosan, Michael J Nissen, Burkhard Möller, Merete L Hetland, Irene E van der Horst-Bruinsma
Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in psoriatic arthritis; results from the EuroSpA Research Collaboration Network. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Thomas Frisell, Hannah Bower, Matilda Morin, Eva Baecklund, Daniela Di Giuseppe, Bénédicte Delcoigne, Nils Feltelius, Helena Forsblad-d'Elia, Elisabet Lindqvist, Ulf Lindström, Johan Askling, null null
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme. Annals of the rheumatic diseases (2023)
Bente Glintborg, Daniela Di Giuseppe, Johan Karlsson Wallman, Dan C Nordström, Bjorn Gudbjornsson, Merete Lund Hetland, Johan Askling, Gerdur Grondal, Tuulikki Sokka, Sella Aarrestad Provan, Brigitte Michelsen, Eirik Klami Kristianslund, Lene Dreyer, Thorvardur Jon Love, Ulf Lindström
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries. Annals of the rheumatic diseases (2023)
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Ulf Lindström, Carl Turesson, Katerina Chatzidionysiou, Elisabet Lindqvist, Ann Knight, Helena Forsblad-d'Elia, Johan Askling
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden. RMD open 9 (4) (2023)
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Ulf Lindström, Carl Turesson, Katerina Chatzidionysiou, Elisabet Lindqvist, Ann Knight, Helena Forsblad-d'Elia, Johan Askling
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden. RMD open 9 (4) (2023)
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Ulf Lindström, Carl Turesson, Katerina Chatzidionysiou, Elisabet Lindqvist, Ann Knight, Helena Forsblad-d'Elia, Johan Askling
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden. RMD open 9 (4) (2023)
Andrei Barbulescu, Johan Askling, Katerina Chatzidionysiou, Helena Forsblad-d'Elia, Alf Kastbom, Ulf Lindström, Carl Turesson, Thomas Frisell
Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data. Rheumatology (Oxford, England) 61 (10) (2022)
Daniela di Giuseppe, Ulf Lindström, Kalle Aaltonen, Heikki Relas, Sella Aarrestad Provan, Bjorn Gudbjornsson, Merete Lund Hetland, Johan Askling, Markku Kauppi, Arni Jon Geirsson, Katerina Chatzidionysiou, Tanja Schjødt Jørgensen, Lene Dreyer, Brigitte Michelsen, Lennart T H Jacobsson, Bente Glintborg
The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries. Rheumatology (Oxford, England) 61 (9) (2022)
Bente Glintborg, Daniela Di Giuseppe, Johan K Wallman, Sella A Provan, Dan Nordström, Anna-Mari Hokkanen, Jenny Österlund, Eirik Kristianslund, Tore K Kvien, Bjorn Gudbjornsson, Merete Lund Hetland, Brigitte Michelsen, Lennart Jacobsson, Johan Askling, Ulf Lindström
Is the risk of infection higher during treatment with secukinumab than with TNF-inhibitors? An observational study from the Nordic countries. Rheumatology (Oxford, England) (2022)
Johan Karlsson Wallman, G-M Alenius, Eva Klingberg, Valgerdur Sigurdardottir, S Wedrén, Sofia Exarchou, Ulf Lindström, Daniela di Giuseppe, Johan Askling, Lennart T H Jacobsson
Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register. Scandinavian journal of rheumatology (2022)
Daniela di Giuseppe, Ulf Lindström, Hannah Bower, Bénédicte Delcoigne, Thomas Frisell, Katerina Chatzidionysiou, Christopher Sjöwall, Elisabet Lindqvist, Johan Askling
Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden. Rheumatology (Oxford, England) 61 (9) (2022)
Michael John Nissen, Bénédicte Delcoigne, Daniela di Giuseppe, Lennart T H Jacobsson, Merete Lund Hetland, Adrian Ciurea, Lucie Nekvindova, Florenzo Iannone, Nurullah Akkoc, Tuulikki Sokka-Isler, Karen Minde Fagerli, Maria Jose Santos, Catalin Codreanu, Manuel Pombo-Suarez, Ziga Rotar, Bjorn Gudbjornsson, Irene van der Horst-Bruinsma, Anne Gitte Loft, Burkhard Möller, Herman Mann, Fabrizio Conti, Gozde Yildirim Cetin, Heikki Relas, Brigitte Michelsen, Pedro Avila Ribeiro, Ruxandra Ionescu, Carlos Sanchez-Piedra, Matija Tomsic, Árni Jón Geirsson, Johan Askling, Bente Glintborg, Ulf Lindström
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis. Rheumatology (Oxford, England) 61 (12) (2022)
Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Gerd-Marie Ahlenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad-d'Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling, null null
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study. Annals of the rheumatic diseases (2021)
Ulf Lindström, Karin Bengtsson, Tor Olofsson, Daniela Di Giuseppe, Bente Glintborg, Helena Forsblad-d'Elia, Lennart T H Jacobsson, Johan Askling
Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter? Annals of the rheumatic diseases 80 (11) (2021)
Ulf Lindström, Daniela Di Giuseppe, Bénédicte Delcoigne, Bente Glintborg, Burkhard Möller, Adrian Ciurea, Manuel Pombo-Suarez, Carlos Sanchez-Piedra, Kari Eklund, Heikki Relas, Bjorn Gudbjornsson, Thorvardur Jon Love, Gareth T Jones, Catalin Codreanu, Ruxandra Ionescu, Lucie Nekvindova, Jakub Závada, Nuh Atas, Servet Yolbas, Karen Minde Fagerli, Brigitte Michelsen, Žiga Rotar, Matija Tomšič, Florenzo Iannone, Maria Jose Santos, Pedro Avila-Ribeiro, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Lennart Th Jacobsson, Johan Askling, Michael J Nissen
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration. Annals of the rheumatic diseases 80 (11) (2021)
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Gerd-Marfie Ahlenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad-d'Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling, null null
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision. RMD open 7 (3) (2021)
Brigitte Michelsen, Ulf Lindström, Catalin Codreanu, Adrian Ciurea, Jakub Zavada, Anne Gitte Loft, Manuel Pombo-Suarez, Fatos Onen, Tore K Kvien, Ziga Rotar, Maria Jose Santos, Florenzo Iannone, Anna-Mari Hokkanen, Bjorn Gudbjornsson, Johan Askling, Ruxandra Ionescu, Michael J Nissen, Karel Pavelka, Carlos Sanchez-Piedra, Servet Akar, Joseph Sexton, Matija Tomsic, Helena Santos, Marco Sebastiani, Jenny Österlund, Arni Jon Geirsson, Gary Macfarlane, Irene van der Horst-Bruinsma, Stylianos Georgiadis, Cecilie Heegaard Brahe, Lykke Midtbøll Ørnbjerg, Merete Lund Hetland, Mikkel Østergaard
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration. RMD open 6 (3) (2021)
Bente Glintborg, Ulf Lindström, Daniela Di Giuseppe, Sella Aarrestad Provan, Bjorn Gudbjornsson, Merete Lund Hetland, Brigitte Michelsen, Johan Karlsson Wallman, Kalle Aaltonen, Anna-Mari Hokkanen, Dan Nordström, Tanja Schjødt Jørgensen, Rebekka Lund Hansen, Arni Jon Geirsson, Kathrine Grøn, Niels Steen Krogh, Johan Askling, Lars Erik Kristensen, Lennart Jacobsson, null null
One-year treatment outcomes of secukinumab versus tumor necrosis factor inhibitors in Spondyloarthritis. Arthritis care & research (2020)
Ulf Lindström, Tor Olofsson, Sara Wedrén, Ilia Qirjazo, Johan Askling
Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice. Arthritis research & therapy 21 (1) (2019)
Ulf Lindström, Bente Glintborg, Daniela Di Giuseppe, Dan Nordström, Sella Aarrestad Provan, Bjorn Gudbjornsson, Johan Askling, Merete Lund Hetland, Kalle Aaltonen, Niels Steen Krogh, Arni Jon Geirsson, Lennart T H Jacobsson
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis. RMD open 5 (2) (2019)
Ulf Lindström, Tor Olofsson, Sara Wedrén, Ilia Qirjazo, Johan Askling
Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study. RMD open 4 (2) (2018)
Ulf Lindström, Sofia Exarchou, Elisabeth Lie, Mats Dehlin, Helena Forsblad-d'Elia, Johan Askling, Lennart Jacobsson
Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study. Arthritis research & therapy 18 (1) (2016)